Intermittent vs continuous infusion for beta-lactams
For many beta-lactams the index that matters most is time above a threshold. That makes how you deliver the dose part of the pharmacology, not a nursing footnote.
Give the same daily amount as short intermittent infusions and you get peaks and troughs. Stretch the infusion and the troughs rise. Run it continuously and the profile can settle toward a steady free concentration. The MIC line does not move. The geometry around it does.
Geometry of infusion mode for simulation. Not a recommendation to change bedside practice by itself.
Same daily dose, different shape
Hold clearance, volume, fu, and MIC fixed. Change only the input rate.
- Intermittent short infusion: oscillating free levels. Success depends on how long each cycle stays above MIC.
- Extended infusion: softer peaks, higher troughs.
- Continuous infusion: approach to steady state. Many analyses then ask whether steady free concentration stays above MIC, or above a multiple of MIC.
Infusion mode changes which parts of the day sit above the MIC line.
Why loading doses appear in continuous regimens
If you start continuous infusion with no load, early concentrations climb slowly. A PTA that only looks at later steady state can miss early undershoot. If your clinical question includes the first hours, model the load.What the simulator must keep honest
- Loading dose status.
- Renal function strata, because steady concentration moves with clearance.
- Administration constraints that your scenario ignores (stability, line access). Label them.
- Target form: percent fT>MIC versus a Css/MIC ratio rule. They are related ideas with different bookkeeping.
Freeze the virtual population and MIC grid. Change only the dosing input. Plot PTA on the same MIC axis. Report early and steady periods if loading differs.
Changing infusion mode and also silently changing daily dose, population, or target definition. Then attributing the whole PTA jump to "continuous infusion magic."
A classroom example without fake precision
Suppose two regimens deliver the same daily free-drug amount, one as intermittent doses and one as continuous infusion after a load. At low MIC both may look fine. As MIC rises, the intermittent troughs fail first while continuous Css may still clear a Css/MIC rule. That pattern is exactly why people study infusion mode. It is also why you must keep daily dose and population fixed when you make the comparison.
How to talk about this without overselling
A fair sentence sounds like this: “Under the same daily dose and the same virtual population, continuous infusion improved PTA at higher MIC values because trough undershoot disappeared; early coverage still depended on the loading dose.”
An unfair sentence sounds like this: “Continuous infusion is better,” with no fixed daily dose, no population lock, and no target definition.
Also remember pharmacy and line realities. A simulation can assume perfect continuous delivery. A ward may not. If your scenario ignores stability windows or access constraints, write that limitation in ordinary language. The PK/PD geometry lesson remains useful either way.
One more practical tip: when two papers disagree about continuous infusion benefit, check whether they locked daily dose, population, free/total handling, and target definition. Many apparent contradictions dissolve once those four locks are compared side by side.
Takeaway
Infusion mode redraws the exposure path around the MIC. For time-driven beta-lactam targets, that redraw is part of the science. Compare shapes under controlled conditions, and say whether your endpoint was interval fT>MIC or steady-state coverage.
Previous: Free drug and protein binding · Next: Joint targets for BL/BLI pairs.